News Highlights: Top Company News of the Day - Thursday at 3 PM ET

Dow Jones
04/25
 
Pepsi and Mountain Dew Depend on Imports. PepsiCo Says Tariffs Will Hurt Earnings. 
 

The maker of Doritos and Cheetos also cited a drop in consumer confidence caused by inflation and the global trade war.

 
Comcast Loses Broadband Customers, Takes Theme-Park Hit From L.A. Fires 
 

The company posted lower quarterly earnings, but found bright spots with its mobile-phone plans and Peacock streaming service.

 
Gold Bull Kaplan Lands 'Holy Grail' Deposit as Precious Metal Hits Records 
 

Billionaire investor Thomas Kaplan is nearing a long-held ambition: control of a big gold deposit in Alaska.

 
Procter & Gamble Cuts Fiscal-Year Guidance 
 

Procter & Gamble lowered its fiscal-year outlook after posting lower sales in the third quarter amid a challenging consumer environment.

 
American Airlines Pulls Full-Year Outlook on Concerns Over Travel Demand 
 

American Chief Executive Robert Isom says he is confident the airline can withstand uncertainty in the economy.

 
Jersey Mike's Hires New CEO After $8 Billion Sale 
 

Charlie Morrison, former Wingstop CEO, will lead the sandwich chain after its sale to Blackstone. Founder Peter Cancro remains board chairman.

 
UPS to Buy Canada's Andlauer Healthcare for $1.6 Billion 
 

United Parcel Service agreed to buy Canada's Andlauer Healthcare Group for roughly $1.6 billion in an effort to grow in healthcare transportation and logistics.

 
Nissan Expects Roughly $5 Billion Net Loss From Impairments, Restructuring Costs 
 

Nissan Motor estimated billions of dollars in net loss for the fiscal year ended March due to impairments and restructuring expenses.

 
Merck Cuts 2025 Outlook on Tariffs, Charges 
 

Merck's first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

 
Bristol Myers Squibb Shares Sink Despite Better-Than-Expected Earnings. The Future Is Cloudy. 
 

Bristol Myers sees revenue decline in its legacy drug portfolio due to competition and Medicare headwinds.

 
 

(END) Dow Jones Newswires

April 24, 2025 15:00 ET (19:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10